Burden of Chronic Obstructive Pulmonary Disease in India: Status, Practices and Prevention

 Abstract

Chronic obstructive pulmonary disease (COPD) is affecting 251 million lives globally and it causes 3.15 million deaths per year More than 90% COPD-related deaths happen in low and middle-income countries. In India, three out of five leading causes of mortalities constitute non- communicable diseases whereas COPD is the second biggest cause of death. The prevalence of COPD has increased by 29.2% by 2016 which is a serious public health concern. The clinicians require treating COPD as per the evidence-based guidelines and managing the comorbidities. To avert the cost of care, an integrated and highly efficient system is required which can promote healthier lifestyle and self-management of the symptoms through a team-based approach comprising different healthcare professionals for delivering planned care. Moreover, smoking and other risk factors should be controlled considering the future benefits of the nation. Also, air pollution and other environmental risk factors are deteriorating day by day in India that is evident in the recently published Environmental Performance Index in which India ranked fourth worst country in the world. To improve the burden of COPD, multifaceted strategies should be adopted to promote positive respiratory health in the individual and population level.

Read more about this article: https://juniperpublishers.com/ijoprs/IJOPRS.MS.ID.555599.php

Read more Juniper Publishers Google Scholar Articles: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=Y8LS2LwAAAAJ&citation_for_view=Y8LS2LwAAAAJ:ldfaerwXgEUC

Comments

Post a Comment

Popular posts from this blog

SARS CoV-2 Vaccination Autoimmunity, Antibody Dependent Covid-19 Enhancement and Other Potential Risks: Beneath the Tip of the Iceberg

  Abstract Nucleic acid based-mRNA based and adenovirus vectored-vaccines, were first ever or first commercially ever approved for the public, respectively. However, these newly emergency approved types possess a potential risk to induce auto-immune diseases e.g., thrombocytopenia, myocarditis and immune induced thrombosis and thromboembolism that might be fatal and could reason for some of the post vaccination sudden death reports. Moreover, all SARS CoV-2 types of vaccines, depending on the spike protein immunogenicity, especially the conventional inactivated ones might increase the likelihood of COVID-19 severity upon re-infection through antibody dependent enhancement which might reason for the recently described abundance of hospital admissions within seven days of vaccination and might also reason for some of the serious adverse effects encountered with administration of convalescent plasma to COVID-19 patients as well as they might share in development of som...
Read more

Effects of Selenium Nanoparticles on Bleomycin-Induced Pulmonary Fibrosis in Rats

  Abstract Background:   Idiopathic pulmonary fibrosis (IPF) is one of the interstitial lung diseases. To date, most drug trials for the treatment of IPF have yielded disappointing results. Recently, selenium nano-particles (SeNP) have received attention for potential use in treatments, due in part to their established abilities to exert size-dependent anti-oxidant/-inflammatory effects. Materials and Methods:   the rats were treated with SeNPs by intraperitoneal injection (0.5mg SeNP/kg) for five consecutive days in the inflammatory phase (a day after injection of bleomycin) and fibrotic phase (a week after injection of bleomycin). Results:   The results showed that administration of SeNP during the inflammatory phase improved the activity of enzymes antioxidant (i.e., glutathione peroxidase and superoxide dismutase) and also led to significant decreases in interleukin (IL)-6 and malondialdehyde (MDA) levels in lung homogenates. Histopathology, measures of lung inde...
Read more

Complication and Sequelae of Pulmonary Tuberculosis: A Tertiary Care Center Experience

  Abstract Background: Tuberculosis (TB) is a grave infectious disease caused by the bacillus Mycobacterium tuberculosis (MTB). Pulmonary tuberculosis remains an important public health problem globally and one of most common infectious disease. Tuberculosis can cause wide variety of complication respiratory or non-respiratory. We studied complication and sequelae of pulmonary tuberculosis. Methodology: A prospective observational study was conducted, the study included all patients presenting with complications of tuberculosis in newly diagnosed and previously treated patients referred to the Pulmonary Medicine Department. Patients not willing to give consent for the study or the patient with incomplete data were excluded. TB was diagnosed on the basis of sputum Gene Expert, Line Probe Assay and Conventional Drug Sensitivity testing. Results: Of the total 310 cases, 176(57%) patients were males and 134(43%) were female patients. The mean age of all patient...
Read more